238 related articles for article (PubMed ID: 25611295)
41. c-MYC targets the central oscillator gene Per1 and is regulated by the circadian clock at the post-transcriptional level.
Repouskou A; Prombona A
Biochim Biophys Acta; 2016 Apr; 1859(4):541-52. PubMed ID: 26850841
[TBL] [Abstract][Full Text] [Related]
42. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
43. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
44. Targeted suppression of metastasis regulatory transcription factor SOX2 in various cancer cell lines using a sequence-specific designer pyrrole-imidazole polyamide.
Malinee M; Kumar A; Hidaka T; Horie M; Hasegawa K; Pandian GN; Sugiyama H
Bioorg Med Chem; 2020 Feb; 28(3):115248. PubMed ID: 31879179
[TBL] [Abstract][Full Text] [Related]
45. Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture.
Best TP; Edelson BS; Nickols NG; Dervan PB
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12063-8. PubMed ID: 14519850
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays.
Kim JW; Zeller KI; Wang Y; Jegga AG; Aronow BJ; O'Donnell KA; Dang CV
Mol Cell Biol; 2004 Jul; 24(13):5923-36. PubMed ID: 15199147
[TBL] [Abstract][Full Text] [Related]
47. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
Lebel R; McDuff FO; Lavigne P; Grandbois M
Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
[TBL] [Abstract][Full Text] [Related]
48. Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide.
Franks A; Tronrud C; Kiakos K; Kluza J; Munde M; Brown T; Mackay H; Wilson WD; Hochhauser D; Hartley JA; Lee M
Bioorg Med Chem; 2010 Aug; 18(15):5553-61. PubMed ID: 20615712
[TBL] [Abstract][Full Text] [Related]
49. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
50. Sequence-selective detection of double-stranded DNA sequences using pyrrole-imidazole polyamide microarrays.
Singh I; Wendeln C; Clark AW; Cooper JM; Ravoo BJ; Burley GA
J Am Chem Soc; 2013 Mar; 135(9):3449-57. PubMed ID: 23379840
[TBL] [Abstract][Full Text] [Related]
51. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
[TBL] [Abstract][Full Text] [Related]
52. Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia.
Chou CJ; Farkas ME; Tsai SM; Alvarez D; Dervan PB; Gottesfeld JM
Mol Cancer Ther; 2008 Apr; 7(4):769-78. PubMed ID: 18413791
[TBL] [Abstract][Full Text] [Related]
53. Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~let-7d in glioblastoma.
Wang Z; Lin S; Zhang J; Xu Z; Xiang Y; Yao H; Ge L; Xie D; Kung HF; Lu G; Poon WS; Liu Q; Lin MC
Oncotarget; 2016 Aug; 7(35):56266-56278. PubMed ID: 27409345
[TBL] [Abstract][Full Text] [Related]
54. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
[TBL] [Abstract][Full Text] [Related]
55. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
56. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of malignant phenotypes of human osteosarcoma cells by a gene silencer, a pyrrole-imidazole polyamide, which targets an E-box motif.
Taniguchi M; Fujiwara K; Nakai Y; Ozaki T; Koshikawa N; Toshio K; Kataba M; Oguni A; Matsuda H; Yoshida Y; Tokuhashi Y; Fukuda N; Ueno T; Soma M; Nagase H
FEBS Open Bio; 2014; 4():328-34. PubMed ID: 24918046
[TBL] [Abstract][Full Text] [Related]
58. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma.
Seitz V; Butzhammer P; Hirsch B; Hecht J; Gütgemann I; Ehlers A; Lenze D; Oker E; Sommerfeld A; von der Wall E; König C; Zinser C; Spang R; Hummel M
PLoS One; 2011; 6(11):e26837. PubMed ID: 22102868
[TBL] [Abstract][Full Text] [Related]
59. Cysteine cyclic pyrrole-imidazole polyamide for sequence-specific recognition in the DNA minor groove.
Morinaga H; Bando T; Takagaki T; Yamamoto M; Hashiya K; Sugiyama H
J Am Chem Soc; 2011 Nov; 133(46):18924-30. PubMed ID: 21985474
[TBL] [Abstract][Full Text] [Related]
60. Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression.
Suk FM; Lin SY; Lin RJ; Hsine YH; Liao YJ; Fang SU; Liang YC
Oncotarget; 2015 Sep; 6(28):25988-6001. PubMed ID: 26317903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
